UNSPSC 51123003: Sparteine

This classification denotes an antiarrhythmic and oxytocic quinolizidine alkaloid with the molecular formula C15H26N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 298897D62S, chemically known as 6-beta,7-alpha,9-alpha,11-alpha-pachycarpinE but more generally known as sparteine, which bears US NIH Compound Identifier 644020. The term SPARTEINE is an International Non-Proprietary Name or INN.

European Medicines Agency schedules sparteine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10613MIG. Most nations, for tariff and trade purposes, schedule sparteine under HS 29399900 and SITC 54149. As of Q4 2014, SPARTEINE remains US FDA's Preferred Term for this commodity. SMILES: C1CCN2CC3CC(C2C1)CN4C3CCCC4.

UNSPSC 51123003 Sparteine (Commodity) covers pharmaceutical compounds sourced for emergency medical use by state and local governments, specifically advanced life support medications supplied to fire-rescue services and emergency medical systems. The scope encompasses individual active pharmaceutical ingredients and prepared injectable medications that meet clinical standards for pre-hospital and acute-care protocols. State and local issuing bodies include city purchasing departments acting on behalf of municipal fire and rescue services, which procure these medications under sealed-bid and firm-price terms with strict expiration, storage, and replacement requirements. Vendors typically warrant product integrity for a minimum of one year and assume responsibility for expired-stock pickup and replacement within contract terms. Accessibility documentation and Safety Data Sheets compliant with OSHA Hazard Communication Standards are standard contract requirements.

The City of Tampa's Purchasing Department posted Bid No. 26-P-00188 on April 24, 2026, seeking advanced life support medications (Labetalol, Epinephrine, Adenosine, and Diltiazem injections in specified unit quantities) for Tampa Fire Rescue with a response deadline of April 8, 2026 (sealed electronic submission through OpenGov eProcurement Portal) and an estimated contract value of $40,000. The one-year contract permits renewal for two additional one-year periods plus unilateral extension for up to three 30-day periods; delivery must occur within ten calendar days of order receipt, with all medications maintaining a minimum nine-month expiration date from acceptance. The solicitation includes a 5 percent bid discount for Small Local Business Enterprise (SLBE) participation, not to exceed $10,000, and awards proceeds to the lowest responsive, responsible bidder within 120 days of bid opening. Recent activity under this code appears limited to Florida; broader geographic prevalence data for state and local sparteine procurement are not supported by the available opportunities block.